At this time, posts about Syntekabio are rapidly increasing on portals and stock communities, and today, foreigners are tentatively estimated to have net purchased 6,000 shares. Syntekabio is known as a genomic big data research company.


As of 11:30 AM on the 15th, Syntekabio's stock price is 25,300 KRW, down 9.96% from the previous day, with a trading volume of 1,198,086 shares, which is 81.71% of the 5-day average trading volume. On September 7th, Syntekabio became a market issue with the news of "continuous rise due to confirmation of the efficacy of a COVID-19 treatment candidate substance."


In addition to Syntekabio, posts by investors are also rapidly increasing for Chong Kun Dang (185750), Jeju Semiconductor (080220), and Hanwha (000880).



※Source: AI Investment Assistant AI Lasso


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing